Pharmacologic evaluation of aletamine (alpha-allylphenethylamine hydrochloride) as an antidepressant.
D000374:Aggression / Q000187:drug effects; D000498:Allyl Compounds / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000633:toxicity; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D004285:Dogs; D004336:Drug Antagonism; D004357:Drug Synergism; D004597:Electroshock; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D011807:Quinolizines / Q000037:antagonists & inhibitors*; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012640:Seizures / Q000139:chemically induced; D014203:Tremorine / Q000037:antagonists & inhibitors; D014363:Tryptamines / Q000494:pharmacology
D000498:Allyl Compounds; D000928:Antidepressive Agents; D010627:Phenethylamines; D011807:Quinolizines; D014363:Tryptamines; D012110:Reserpine; D014203:Tremorine; D009638:Norepinephrine